N@N

Why Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short Sellers

The article from MSN discusses why Pacific Biosciences of California (PacBio) is considered the worst ARK stock to buy according to short sellers. PacBio, known for its long-read sequencing technology, has seen its stock plummet by 50% in the last year, making it a prime target for short sellers. The skepticism around PacBio stems from its high cash burn rate, with the company reporting a net loss of $195 million in the last quarter, despite a revenue increase. Short interest in PacBio has surged, with 25% of its float being shorted, reflecting doubts about its profitability and the sustainability of its business model. Critics argue that while PacBio's technology is innovative, the company's path to profitability remains unclear, especially given the competitive landscape of genetic sequencing where other companies like Illumina also operate. Additionally, the article mentions that ARK Invest, led by Cathie Wood, has been reducing its stake in PacBio, further signaling concerns about its future performance.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/technology/tech-companies/why-pacific-biosciences-of-california-pacb-is-the-worst-ark-stock-to-buy-according-to-short-sellers/ar-AA1vGhpP ]